| Literature DB >> 20374741 |
Nancy Kedersha1, Paul Anderson.
Abstract
Stress necessitates rapid reprogramming of translation in order to facilitate an adaptive response and promote survival. Cytoplasmic stress granules (SGs) and processing bodies (PBs) are dynamic structures that form in response to stress-induced translational arrest. PBs are linked to mRNA silencing and decay, while SGs are more closely linked to translation and the sorting of specific mRNAs for different fates. While they share some components and can interact physically, SGs and PBs are regulated independently, house separate functions, and contain unique markers. SG formation is associated with numerous disease states, and the expanding list of SG-associated proteins integrates SG formation with other processes such as transcription, splicing, and survival. Growing evidence suggests that SG assembly is initiated by translational arrest, and mediates cross talk with many other signaling pathways.Entities:
Mesh:
Year: 2009 PMID: 20374741 PMCID: PMC7102815 DOI: 10.1016/S1877-1173(09)90004-7
Source DB: PubMed Journal: Prog Mol Biol Transl Sci ISSN: 1877-1173 Impact factor: 3.622
SG and PB Associated Proteins
| Protein | SG/PB localization | References | Nucleation | Knockdown effects on SGs or PBs | Function | Location | SG/PB partners |
|---|---|---|---|---|---|---|---|
| Ago1 | PBs and SGs | SGs and PBs | None | Gene silencing | Cyt | GW182 | |
| Ago2 | PBs and SGs | SGs and PBs | None | siRNA, slicer | Cyt | FXR1, GW182, PACT | |
| AKAP350A | SGs | KD reduces SG size | Protein scaffold | Cyt, Golgi | Caprin-1, CCAR, G3BP | ||
| APOBEC1 | SGs not PBs | NK, PA | RNA editing | Cyt | |||
| APOBEC3G | SGs and PBs | No | Cytidine deaminase, antiviral | Cyt | |||
| Ataxin-2 | SGs not PBs | No | KD reduces SGs | Translation | Cyt | PABP | |
| Calreticulin | SGs | Cyt, ER | arginine-modified | ||||
| CCAR1 | SGs | KD reduces SGs | Transcriptional coactivator | Nuc>Cyt | AKAP350, wnt signaling | ||
| CCR4 | PBs | Transcription, ribosome biogenesis | Cyt | 10 protein complex | |||
| Caprin-1 | SGs | Yes | KD reduces SGs | Cell cycle | Cyt>Nuc | G3BP | |
| CIRP | SG | Yes | Translational silencer | Nuc>Cyt | |||
| CPEB1 | SGs and PBs | Yes | Translational silencer | Cyt | |||
| DAP5 | SGs | Translation | Cyt | ||||
| DBPA | SG | Splicing | Nuc>Cyt | ||||
| DCP1 | PBs not SGs | No | mRNA Decay | Cyt | Hedls | ||
| DCP2 | PBs not SGs | No | mRNA decay | Cyt | |||
| DDX1 | SGs | ds DNA breaks, UV | Nuc>Cyt | ||||
| DDX3 | SGs | RNA helicase | Shuttles | ||||
| DIS 1 | SGs | Overexpressed only | Cyt | eIF3 | |||
| DLC2a (dyein LC2A) | SGs | KD reduces SGs | Cyt | TIA-1, HuR | |||
| edc1,2 | PBs | mRNA decay | Cyt | ||||
| edc3 | PBs | Cyt | |||||
| eIF1 | SGs not PBs | NK, PA | Translation initiation | Cyt | |||
| eIF2α | Variable at SGs | S51D mutant nucleates SGs | S51A mutant inhibits | Translation initiation | Cyt>Nuc | ||
| eIF3 | SGs not PBs | eIF3p48 nucleates SGs; eIF3p44 inhibits SGs | Translation initiation | Cyt | |||
| eIF4A, B | SGs only | No | RNA helicase, translation | Cyt>nuc | |||
| eIF4E | SGs and PBs | No | Translation, cap binding | Cyt>nuc | |||
| eIF4G | SG not PBs | Translation initiation | Cyt | ||||
| eIF4E-T | PBs not SGs | No | mRNA decay | Cyt | |||
| eIF4H | SGs not PBs | NK/PA | Translation | Cyt | |||
| EWS | SGs | SGs | Oncogene | Nuc>cyt | |||
| FAK | SGs | Motility, signaling | Cyt | ||||
| FAST | PBs, SGs | SGs and PBs | No effect | Signaling | Nuc, cyt | ||
| FMRP/FXR1 | SGs not PBs | SGs | KD reduces SG | Translation, splicing, microRNA | Cyt>nuc | ||
| FBP/KSRP | SGs | KH3-domain nucleates SGs | mRNA decay, miRNA processing | Nuc>cyt | |||
| FUS | SGs | SGs | Motility | N>cyt | |||
| GRB7 | SGs | Protein scaffold | Cyt | ||||
| GW182, TNRC6B | PBs, not SGs | No | KD bk PB | siRNA | Cyt | ||
| G3BP | SGs not PBs | SGs | S149E mutant reduces SGs | Helicase, protein scaffold | Nuc>cyt, shuttles | Caprin1, USP10 | |
| HDAC6 | SGs not PBs | No | Truncation reduces SGs | Deacetylase, stress signaling | Cyt | ||
| Hedls/Ge-1 | PBs not SGs | PBs | Enhances mRNA decapping | Cyt | |||
| hnRNP A1 | SGs | No | Splicing, multifunctional | Nuc>cyt | |||
| hnRNP A3 | PBs not SGs | Splicing, multifunctional | Nuc>cyt | NXF7 | |||
| hnRNP K | SGs | No | mRNA processing | Nuc>cyt | RBM42 | ||
| hnRNPQ | SGs (and PBs?) | Splicing | Nuc>cyt | APOBEC1 | |||
| HSP27 | SGs (HS) | Heat shock | Cyt>nuc | ||||
| HSP90 | SGs not PBs | Inactivation reduces PBs | Molecular chaperone | ||||
| HuR | SGs or PBs | No | Stability, splicing | Nuc>cyt | |||
| Importin 8 | PBs and SGs | No | Shuttling | ||||
| IP5K Ins (1,3,4,5,6) | SGs (GFP) | SGs | Protein scaffold, not a kinase | Shuttles | |||
| KSRP aka FUBP2 | SGs or PBs arg meth/SMN | microRNA proc, splicing, ARE stability | Nuc>cyt | 14-3-3 SMN | |||
| Lin28 | SGs and PBs, stem cells | Block let7 processing | Cyt>nuc, shuttles | ||||
| Line1-ORFp | SGs | SGs | Transposon | ||||
| Lsm1 | PBs>SGs | No | |||||
| MBNL1 | SGs | Alternative splicing | Nuc>cyt | ||||
| hMEX-3B | SGs, PBs | SGs and PBs | Germline development | Shuttles | 14-3-3, Ago1 | ||
| MLN51 | SGs | No | KD reduces SGs | EJC, splicing | |||
| MOV10/Armitage | PBs | RNA-directed transcription | |||||
| Musashi | SGs and PBs | No | PABP | ||||
| NXF7 | PBs | PBs, SG | mRNA export | Nuc>cyt | hnRNPs, KSRP | ||
| PABP | SGs not PBs | KD reduces SGs | Translation | Shuttles | |||
| p54/RCK | PBs and SGs | yes | Translation/decay | Cyt | |||
| P58 (TFL) | PBs not SGs | Cell-cycle control | |||||
| PACT | SGs | Loads RISC, PKR activator | Ago2, PKR | ||||
| Pat1 | PBs | Decapping | Cyt | ||||
| PAI-RBP1 | SGs | ||||||
| PCP1. 2 (hnRNP E1,2) | SGs and PBs | IRES, neuronal granules | Nuc>cyt | ||||
| Plakophillin1/3 | SGs | No | Adhesion | Cyt | G3BP | ||
| PMR1 | SGs | No | Endonuclease | Cyt | |||
| Pumilio 2 | SGs | Yes | KD reduces SG | Development | Nuc | ||
| RACK1 | SGs | Yes | Signaling, polarity | Cyt | |||
| Rap55/Lsm14 | SGs and PBs | No | KD reduces PBs | Cyt | |||
| RBM42 | SG not PB | No | Nuc>cyt | ||||
| RHAU helicase | SGs | No | No | RNA helicase | Nuc>cyt | ||
| RSK2 | SG | Kinase | Cyt | TIA-1 | |||
| Roquin | SGs and PBs | Yes-PBs? | E3 ligase | Cyt | |||
| Rpp20 | SGs | No | RNAse P subunit | ||||
| Rpb4 (pol II subunit) | SGs | mRNA transcription | Nuc | ||||
| SAM68 | SG subset | No mutant nucleates | Multifunction, alternative splicing | Nuc>cyt | |||
| SGNP | SGS | Ribosome maturation? | Nucleolar | ||||
| SRC3 | SGs not PB | No | Transcriptional coactivator | Nuc>cyt | |||
| Smaug | SGs and PBs | SGs and PBs | Translational silencing | Cyt | |||
| Staufen | SGs | No | KD promotes SGs. Overxpression reduces SGs | ds RNA binding | Cyt | ||
| SMN | SGs | Yes | no | snRNP assembly | Nuc, cyt | ||
| TAF15 | SGs | Yes | Oncogene | Nuc>cyt | |||
| TIA-1/TIAR | SGs>PBs | Yes | KD reduces SG | Splicing, translational silencer | Shuttles, Nuc>cyt | ||
| TNRC6B (GW182 fam) | PBs | KD reduces PBs | microRNA silencing | ||||
| TRAF-2 | SGs not PBs | No | No | Signaling | |||
| TTP/BRF-1 | SGs and PBs | Yes | No | mRNA decay | Cyt>nuc, shuttles | ||
| TUDOR-3 | SGs | Binds FMRP | |||||
| TSN | SGs | No | Antiviral nuclease | G3BP | |||
| Ubiquitin | SGs | No | Signaling, protein turnover | Nuc>cyt | |||
| Xrn1 | PBs and SGs | Yes | mRNA decay | Cyt | |||
| YB-1 | SGs and PBs | mRNA chaperone | Nuc>cyt | ||||
| ZBP1 (zipcode BP) | SGs | No | mRNA localization | ||||
| ZBP1 (ZDNA BP) | SGs | Antiviral |
Nuc, nuclear localization; Cyt, cytoplasmic localization. NK/PA, unpublished.
“Nucleation” refers to the ability of an ectopically expressed protein to induce SG or PB assembly. KD, knockdown.
Stress and Pharmacological Induces of SGs and PBs
| Drug | Mode of action | Effect on SGs | Effect on PBs |
|---|---|---|---|
| Arsenite | Oxidative stressor, activates HRI, induces phosphorylation of eIF2α. Induces HSPs and GRPs | Strong inducer, SGs often adjacent to PBs | Strong inducer; PBs often adjacent to SGs |
| Clotrimazole | Inhibits Hexokinase II, causes energy starvation | Induces | No effect |
| Cycloheximide | Blocks elongation, activates SAPK | Blocks/disassembles | Blocks/disassembles |
| Edeine | Impairs initiation, blocks 60S joining | Induces | ? |
| Emetine | Blocks elongation, does not activate SAPK | Blocks/disassembles | Blocks/disassembles |
| FCCP | Mitochondrial poison, collapses proton gradient | Induces (CTS) | No effect/disassembles (CTS) |
| Heat shock | Protein denaturation, activates GCN2 | Induces | May induce, after SGs disperse |
| Hippuristanol | Inactivates eIF4A, impairs eIF4F/scanning | Induces | ? |
| MG132 | Inhibits chymotryptic proteases including proteasome, activates autophagy | Weakly induces (CTS) | No effect |
| Pateamine A | Inactivates eIF4A, impairs eIF4F/scanning | Induces | No effect |
| Puromycin | Promotes termination | Weakly induces | May enlarge |
| Sorbitol | Osmotic stress | Induces | No effect |
| Thapsigargin | ER stress, releases Ca2+ | Induces | No effect |
CTS, “cell type specific” effect occurs in some cell lines but not others.
Fig. 1Model depicting the graded stages of SG assembly. Stalled initiation allows elongating ribosomes to leave polysomes, resulting in stalled 48S mRNPs which recruit available cytoplasmic RNA-binding proteins (blue region), many of which would normally shuttle into the nucleus (pink area). Locally high concentrations of mRNPs promote aggregation into small complexes, which progressively fuse into larger aggregates, assisted by microtubule-dependent motors. Sorting ensues as the higher affinity interactions prevail, and as other signaling molecules are recruited. Subsets of mRNPs may be removed from the SGs pending phosphorylation and 14-3-3 binding and shunted to PBs for decay (e.g., TTP). Other mRNPs may be exported for other fates.